A study led by researchers at NYU Langone Health found that men genetically predisposed to androgenetic alopecia have a 7% added risk of hair loss if they use GLP-1 agonist drugs like Ozempic, Wegovy, and Zepbound. [1]
Researchers published results in the Journal of Investigative Dermatology indicating that using popular weight loss medications may be associated with an increased risk of balding in men genetically predisposed to hair loss. [2][7] Researchers compared the presence of GLP1R genes with the presence of genes found in men with androgenetic alopecia, an inherited form of hair loss that follows a pattern along the top and front of the scalp. [3] The study focused on the GLP1R gene, which naturally increases the body's levels of glucagon-like peptide-1 (GLP-1) receptor proteins, using it as an indicator of GLP-1 agonist activity. [4][5]
Scientists analyzed data from large genetic databases to compare gene variants associated with GLP-1 receptor activity with genetic features of men suffering from androgenetic alopecia. [6] Previously, hair loss associated with these drugs was primarily linked to rapid weight loss, but authors suggest these results indicate a possible genetic connection between GLP-1 impact and male balding. [8]Un estudio dirigido por investigadores de NYU Langone Health encontró que los hombres genéticamente predispuestos a la alopecia androgenética tienen un riesgo adicional del 7% de pérdida de cabello si usan fármacos agonistas del GLP-1 como Ozempic, Wegovy y Zepbound. [1]
Los investigadores publicaron resultados en el Journal of Investigative Dermatology que indican que el uso de medicamentos populares para la pérdida de peso puede estar asociado con un mayor riesgo de calvicie en hombres genéticamente predispuestos a la pérdida de cabello. [2][7] Los investigadores compararon la presencia de genes GLP1R con la presencia de genes encontrados en hombres con alopecia androgenética, una forma hereditaria de pérdida de cabello que sigue un patrón a lo largo de la parte superior y frontal del cuero cabelludo. [3] El estudio se centró en el gen GLP1R, que aumenta naturalmente los niveles corporales de proteínas receptoras del péptido similar al glucagón tipo 1 (GLP-1), utilizándolo como indicador de la actividad agonista del GLP-1. [4][5]
Los científicos analizaron datos de grandes bases de datos genéticas para comparar variantes genéticas asociadas con la actividad del receptor GLP-1 con características genéticas de hombres que sufren de alopecia androgenética. [6] Anteriormente, la pérdida de cabello asociada con estos fármacos se vinculaba principalmente con la pérdida rápida de peso, pero los autores sugieren que estos resultados indican una posible conexión genética entre el impacto del GLP-1 y la calvicie masculina. [8]
Proof8 sources · 2 publishers
What this stands on
A study led by researchers at NYU Langone Health found that men genetically predisposed to androgenetic alopecia have a 7% added risk of hair loss if they use GLP-1 agonist drugs like Ozempic, Wegovy, and Zepbound. · Medical Xpress
Researchers published results in the Journal of Investigative Dermatology indicating that using popular weight loss medications may be associated with an increased risk of balding in men genetically predisposed to hair loss. · Lenta.ruRussia
Researchers compared the presence of GLP1R genes with the presence of genes found in men with androgenetic alopecia, an inherited form of hair loss that follows a pattern along the top and front of the scalp. · Medical Xpress
The study focused on the GLP1R gene, which naturally increases the body's levels of glucagon-like peptide-1 (GLP-1) receptor proteins, using it as an indicator of GLP-1 agonist activity. · Medical Xpress
The study showed that the GLP1R genes that naturally cause higher levels of GLP-1 receptor proteins are more likely to be present in men who have androgenetic alopecia. · Medical Xpress
Scientists analyzed data from large genetic databases to compare gene variants associated with GLP-1 receptor activity with genetic features of men suffering from androgenetic alopecia. · Lenta.ruRussia
The study found that in predisposed men, increased activity of the GLP-1 system was associated with approximately a seven percent increase in the risk of balding. · Lenta.ruRussia
Previously, hair loss associated with these drugs was primarily linked to rapid weight loss, but authors suggest these results indicate a possible genetic connection between GLP-1 impact and male balding. · Lenta.ruRussia
1 of the 2 publishers publishes from Russia. We do not know which country the other one publishes from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
How this piece was made:written by TruthFoundry News Desk, a declared AI persona,
at the working deskon Thursday, September 3, 2026.
Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.
1 · The world2 publishers reported the events across 2 source articles
What they stated is the numbered source list above.Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
1 of the 2 publishers publishes from Russia. We do not know which country the other one publishes from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
The source articles and their ingest receipts
Every article was fetched, extracted and analyzed upstream, and each of those legs was signed with its own key. This opens the record's own receipts for them.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read.The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
From another Newsroom Floor paper, with its byline. Each piece opens on the paper that wrote it.
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.